BIOGEN Idec Inc reported second-quarter earnings that topped expectations yesterday but sales of its key multiple sclerosis drug Tysabri were lower than expected, pushing the company’s shares down as much as 2.7%.

US stocks moved down today as investors weighed rising US incomes and consumer spending against lofty oil prices.

THE ISEQ Index of shares performed poorly again yesterday, dropping 29.88 points to close at 4313.45.